Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer.

Xue, Hui; Qiu, Bin; Wang, Hao; Jiang, Ping; Zhang, Weiwei; Xue, Lixiang; Wang, Junjie

Xue, Hui; Qiu, Bin; Wang, Hao; Jiang, Ping; Zhang, Weiwei; Xue, Lixiang; Wang, Junjie.

Afiliação

Xue H; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Qiu B; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Wang H; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Jiang P; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Zhang W; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Xue L; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Wang J; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.

Acta Biochim Biophys Sin (Shanghai) ; 54(8): 1193-1196, 2022 08 25.

Article em En | MEDLINE | ID: mdl-35983975

Assuntos

Antígeno B7-H1; Glioma; Glioma/genética; Humanos; Proteínas com Domínio MARVEL/genética; Proteínas com Domínio MARVEL/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Glioma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Biochim Biophys Sin (Shanghai) Assunto da revista: BIOFISICA / BIOQUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google